Loading data
ORKANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 100.64 m USD | — | 1.01 m USD | 4.75 m USD | 13.83 m USD |
| Operating profit | -122.05 m USD | -88.12 m USD | -7.3 m USD | -10.6 m USD | -19.34 m USD |
| Profit before tax | -105.43 m USD | — | — | — | — |
| Income tax expense | — | — | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -105.43 m USD | -83.72 m USD | -5.34 m USD | -9.93 m USD | -19.32 m USD |
| Basic earnings per share | — | — | -0.37 USD/share | -0.69 USD/share | -1.39 USD/share |
| Diluted earnings per share | — | — | -0.37 USD/share | -0.69 USD/share | -1.39 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.